BioMarin Pharmaceutical
BMRN
#1907
Rank
S$13.29 B
Marketcap
S$69.20
Share price
-0.78%
Change (1 day)
-21.86%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Cash on Hand

Cash on Hand as of September 2025 : S$1.91 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has S$1.91 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioMarin Pharmaceutical - Cash on Hand chart (from 1999 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$1.54 B9.04%
2023-12-31S$1.41 B-18.09%
2022-12-31S$1.73 B26.32%
2021-12-31S$1.37 B-2.75%
2020-12-31S$1.40 B38.69%
2019-12-31S$1.01 B-31.39%
2018-12-31S$1.48 B-20.66%
2017-12-31S$1.86 B63.37%
2016-12-31S$1.14 B36.34%
2015-12-31S$0.83 B-32.88%
2014-12-31S$1.24 B25.62%
2013-12-31S$0.99 B81.55%
2012-12-31S$0.54 B116.75%
2011-12-31S$0.25 B-28.44%
2010-12-31S$0.35 B-16.35%
2009-12-31S$0.42 B-47.27%
2008-12-31S$0.80 B-5%
2007-12-31S$0.84 B90.25%
2006-12-31S$0.44 B456.61%
2005-12-31S$79.57 M-0.08%
2004-12-31S$79.63 M-77.29%
2003-12-31S$0.35 B173.13%
2002-12-31S$0.12 B-47.11%
2001-12-31S$0.24 B248.32%
2000-12-31S$69.67 M-33.56%
1999-12-31S$0.10 B575.75%
1998-12-31S$15.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$0.55 B-71.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$38.37 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.11 B-93.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$13.54 B 607.24%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$0.34 B-82.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.89 B-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA